The over-expression of FOXO3a in CML cells combined with TKIs to reduce proliferation, with similar results seen for inhibitors of PI3K/AKT/mTOR signaling. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.